nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—XDH—Carboplatin—uterine cancer	0.341	0.427	CbGbCtD
Pyrazinamide—XDH—Doxorubicin—uterine cancer	0.195	0.244	CbGbCtD
Pyrazinamide—CYP1A2—Progesterone—uterine cancer	0.0833	0.104	CbGbCtD
Pyrazinamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0659	0.0825	CbGbCtD
Pyrazinamide—CYP3A4—Progesterone—uterine cancer	0.0437	0.0546	CbGbCtD
Pyrazinamide—CYP1A2—Etoposide—uterine cancer	0.0373	0.0467	CbGbCtD
Pyrazinamide—CYP3A4—Etoposide—uterine cancer	0.0195	0.0244	CbGbCtD
Pyrazinamide—CYP3A4—Doxorubicin—uterine cancer	0.0133	0.0167	CbGbCtD
Pyrazinamide—Porphyrin metabolism disorder—Progesterone—uterine cancer	0.0133	0.0859	CcSEcCtD
Pyrazinamide—Porphyrin metabolism disorder—Medroxyprogesterone Acetate—uterine cancer	0.012	0.0779	CcSEcCtD
Pyrazinamide—Clotting—Progesterone—uterine cancer	0.00778	0.0504	CcSEcCtD
Pyrazinamide—Clotting—Medroxyprogesterone Acetate—uterine cancer	0.00705	0.0457	CcSEcCtD
Pyrazinamide—Digestion impaired—Progesterone—uterine cancer	0.00416	0.0269	CcSEcCtD
Pyrazinamide—XDH—uterine cervix—uterine cancer	0.00393	0.0846	CbGeAlD
Pyrazinamide—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.00377	0.0244	CcSEcCtD
Pyrazinamide—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.00373	0.0242	CcSEcCtD
Pyrazinamide—XDH—renal system—uterine cancer	0.00367	0.0791	CbGeAlD
Pyrazinamide—Coagulopathy—Progesterone—uterine cancer	0.00357	0.0231	CcSEcCtD
Pyrazinamide—Hepatomegaly—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.0231	CcSEcCtD
Pyrazinamide—XDH—endometrium—uterine cancer	0.00355	0.0765	CbGeAlD
Pyrazinamide—XDH—mammalian vulva—uterine cancer	0.00343	0.074	CbGeAlD
Pyrazinamide—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.0213	CcSEcCtD
Pyrazinamide—Coagulopathy—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.021	CcSEcCtD
Pyrazinamide—AOX1—myometrium—uterine cancer	0.00321	0.0691	CbGeAlD
Pyrazinamide—XDH—female reproductive system—uterine cancer	0.00294	0.0634	CbGeAlD
Pyrazinamide—Hepatomegaly—Dactinomycin—uterine cancer	0.00278	0.018	CcSEcCtD
Pyrazinamide—XDH—vagina—uterine cancer	0.00266	0.0573	CbGeAlD
Pyrazinamide—Hepatotoxicity—Dactinomycin—uterine cancer	0.00254	0.0165	CcSEcCtD
Pyrazinamide—Coagulopathy—Dactinomycin—uterine cancer	0.00252	0.0163	CcSEcCtD
Pyrazinamide—AOX1—uterine cervix—uterine cancer	0.00249	0.0537	CbGeAlD
Pyrazinamide—AOX1—decidua—uterine cancer	0.00238	0.0512	CbGeAlD
Pyrazinamide—AOX1—renal system—uterine cancer	0.00233	0.0503	CbGeAlD
Pyrazinamide—AOX1—endometrium—uterine cancer	0.00226	0.0486	CbGeAlD
Pyrazinamide—AOX1—mammalian vulva—uterine cancer	0.00218	0.047	CbGeAlD
Pyrazinamide—AOX1—uterus—uterine cancer	0.00208	0.0448	CbGeAlD
Pyrazinamide—AOX1—female reproductive system—uterine cancer	0.00187	0.0403	CbGeAlD
Pyrazinamide—Hepatotoxicity—Etoposide—uterine cancer	0.00184	0.0119	CcSEcCtD
Pyrazinamide—AOX1—female gonad—uterine cancer	0.0017	0.0366	CbGeAlD
Pyrazinamide—AOX1—vagina—uterine cancer	0.00169	0.0364	CbGeAlD
Pyrazinamide—Dysuria—Progesterone—uterine cancer	0.00163	0.0106	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Etoposide—uterine cancer	0.00153	0.00993	CcSEcCtD
Pyrazinamide—Body temperature increased—Carboplatin—uterine cancer	0.00149	0.00967	CcSEcCtD
Pyrazinamide—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00957	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Etoposide—uterine cancer	0.00145	0.00938	CcSEcCtD
Pyrazinamide—Hepatitis—Progesterone—uterine cancer	0.0014	0.00904	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Etoposide—uterine cancer	0.00129	0.00837	CcSEcCtD
Pyrazinamide—CYP1A2—renal system—uterine cancer	0.00128	0.0276	CbGeAlD
Pyrazinamide—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00819	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Progesterone—uterine cancer	0.00113	0.0073	CcSEcCtD
Pyrazinamide—Hepatomegaly—Epirubicin—uterine cancer	0.00113	0.00729	CcSEcCtD
Pyrazinamide—Malaise—Progesterone—uterine cancer	0.0011	0.0071	CcSEcCtD
Pyrazinamide—AOX1—lymph node—uterine cancer	0.00109	0.0236	CbGeAlD
Pyrazinamide—Hepatomegaly—Doxorubicin—uterine cancer	0.00104	0.00675	CcSEcCtD
Pyrazinamide—Myalgia—Progesterone—uterine cancer	0.00103	0.0067	CcSEcCtD
Pyrazinamide—Arthralgia—Progesterone—uterine cancer	0.00103	0.0067	CcSEcCtD
Pyrazinamide—Discomfort—Progesterone—uterine cancer	0.00102	0.00662	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00662	CcSEcCtD
Pyrazinamide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000993	0.00643	CcSEcCtD
Pyrazinamide—Hepatitis—Dactinomycin—uterine cancer	0.000987	0.00639	CcSEcCtD
Pyrazinamide—Anorexia—Progesterone—uterine cancer	0.000946	0.00612	CcSEcCtD
Pyrazinamide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00607	CcSEcCtD
Pyrazinamide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00607	CcSEcCtD
Pyrazinamide—CYP3A4—renal system—uterine cancer	0.000927	0.02	CbGeAlD
Pyrazinamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.006	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000904	0.00585	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00088	0.0057	CcSEcCtD
Pyrazinamide—Dyspepsia—Progesterone—uterine cancer	0.000873	0.00565	CcSEcCtD
Pyrazinamide—Decreased appetite—Progesterone—uterine cancer	0.000862	0.00558	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Epirubicin—uterine cancer	0.000859	0.00557	CcSEcCtD
Pyrazinamide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.00555	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000856	0.00555	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000819	0.0053	CcSEcCtD
Pyrazinamide—Feeling abnormal—Progesterone—uterine cancer	0.000817	0.00529	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Epirubicin—uterine cancer	0.000812	0.00526	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000797	0.00516	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Doxorubicin—uterine cancer	0.000795	0.00515	CcSEcCtD
Pyrazinamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00512	CcSEcCtD
Pyrazinamide—Urticaria—Progesterone—uterine cancer	0.000788	0.0051	CcSEcCtD
Pyrazinamide—Body temperature increased—Progesterone—uterine cancer	0.000784	0.00508	CcSEcCtD
Pyrazinamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.00506	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000776	0.00503	CcSEcCtD
Pyrazinamide—Malaise—Dactinomycin—uterine cancer	0.000775	0.00502	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Doxorubicin—uterine cancer	0.000751	0.00486	CcSEcCtD
Pyrazinamide—CYP3A4—female reproductive system—uterine cancer	0.000742	0.016	CbGeAlD
Pyrazinamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000741	0.0048	CcSEcCtD
Pyrazinamide—Myalgia—Dactinomycin—uterine cancer	0.000731	0.00474	CcSEcCtD
Pyrazinamide—Hypersensitivity—Progesterone—uterine cancer	0.000731	0.00473	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Epirubicin—uterine cancer	0.000725	0.00469	CcSEcCtD
Pyrazinamide—Discomfort—Dactinomycin—uterine cancer	0.000723	0.00468	CcSEcCtD
Pyrazinamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000714	0.00462	CcSEcCtD
Pyrazinamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000711	0.0046	CcSEcCtD
Pyrazinamide—Pruritus—Progesterone—uterine cancer	0.000702	0.00454	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000686	0.00445	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Doxorubicin—uterine cancer	0.00067	0.00434	CcSEcCtD
Pyrazinamide—Anorexia—Dactinomycin—uterine cancer	0.000668	0.00433	CcSEcCtD
Pyrazinamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.00429	CcSEcCtD
Pyrazinamide—Photosensitivity—Epirubicin—uterine cancer	0.000659	0.00427	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000639	0.00414	CcSEcCtD
Pyrazinamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00412	CcSEcCtD
Pyrazinamide—Vomiting—Progesterone—uterine cancer	0.000631	0.00408	CcSEcCtD
Pyrazinamide—Rash—Progesterone—uterine cancer	0.000625	0.00405	CcSEcCtD
Pyrazinamide—Dermatitis—Progesterone—uterine cancer	0.000625	0.00405	CcSEcCtD
Pyrazinamide—Photosensitivity—Doxorubicin—uterine cancer	0.00061	0.00395	CcSEcCtD
Pyrazinamide—Decreased appetite—Dactinomycin—uterine cancer	0.000609	0.00395	CcSEcCtD
Pyrazinamide—Nausea—Progesterone—uterine cancer	0.000589	0.00382	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dactinomycin—uterine cancer	0.000578	0.00374	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Etoposide—uterine cancer	0.000577	0.00374	CcSEcCtD
Pyrazinamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000571	0.0037	CcSEcCtD
Pyrazinamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000567	0.00367	CcSEcCtD
Pyrazinamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000566	0.00367	CcSEcCtD
Pyrazinamide—Malaise—Etoposide—uterine cancer	0.000561	0.00363	CcSEcCtD
Pyrazinamide—Body temperature increased—Dactinomycin—uterine cancer	0.000554	0.00359	CcSEcCtD
Pyrazinamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000534	0.00346	CcSEcCtD
Pyrazinamide—Discomfort—Etoposide—uterine cancer	0.000523	0.00339	CcSEcCtD
Pyrazinamide—Hypersensitivity—Dactinomycin—uterine cancer	0.000517	0.00335	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Etoposide—uterine cancer	0.000497	0.00322	CcSEcCtD
Pyrazinamide—Anorexia—Etoposide—uterine cancer	0.000484	0.00313	CcSEcCtD
Pyrazinamide—Dysuria—Epirubicin—uterine cancer	0.000468	0.00303	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Epirubicin—uterine cancer	0.000457	0.00296	CcSEcCtD
Pyrazinamide—Vomiting—Dactinomycin—uterine cancer	0.000446	0.00289	CcSEcCtD
Pyrazinamide—Rash—Dactinomycin—uterine cancer	0.000442	0.00286	CcSEcCtD
Pyrazinamide—Decreased appetite—Etoposide—uterine cancer	0.000441	0.00286	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000438	0.00284	CcSEcCtD
Pyrazinamide—Dysuria—Doxorubicin—uterine cancer	0.000433	0.0028	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000422	0.00274	CcSEcCtD
Pyrazinamide—Feeling abnormal—Etoposide—uterine cancer	0.000418	0.00271	CcSEcCtD
Pyrazinamide—Nausea—Dactinomycin—uterine cancer	0.000416	0.0027	CcSEcCtD
Pyrazinamide—Urticaria—Etoposide—uterine cancer	0.000403	0.00261	CcSEcCtD
Pyrazinamide—Body temperature increased—Etoposide—uterine cancer	0.000401	0.0026	CcSEcCtD
Pyrazinamide—Hepatitis—Epirubicin—uterine cancer	0.0004	0.00259	CcSEcCtD
Pyrazinamide—Hypersensitivity—Etoposide—uterine cancer	0.000374	0.00242	CcSEcCtD
Pyrazinamide—Hepatitis—Doxorubicin—uterine cancer	0.00037	0.0024	CcSEcCtD
Pyrazinamide—Pruritus—Etoposide—uterine cancer	0.000359	0.00233	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000323	0.00209	CcSEcCtD
Pyrazinamide—Vomiting—Etoposide—uterine cancer	0.000323	0.00209	CcSEcCtD
Pyrazinamide—Rash—Etoposide—uterine cancer	0.00032	0.00207	CcSEcCtD
Pyrazinamide—Dermatitis—Etoposide—uterine cancer	0.00032	0.00207	CcSEcCtD
Pyrazinamide—Malaise—Epirubicin—uterine cancer	0.000314	0.00204	CcSEcCtD
Pyrazinamide—Nausea—Etoposide—uterine cancer	0.000301	0.00195	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000299	0.00194	CcSEcCtD
Pyrazinamide—Arthralgia—Epirubicin—uterine cancer	0.000297	0.00192	CcSEcCtD
Pyrazinamide—Myalgia—Epirubicin—uterine cancer	0.000297	0.00192	CcSEcCtD
Pyrazinamide—Discomfort—Epirubicin—uterine cancer	0.000293	0.0019	CcSEcCtD
Pyrazinamide—Malaise—Doxorubicin—uterine cancer	0.000291	0.00188	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000278	0.0018	CcSEcCtD
Pyrazinamide—Myalgia—Doxorubicin—uterine cancer	0.000275	0.00178	CcSEcCtD
Pyrazinamide—Arthralgia—Doxorubicin—uterine cancer	0.000275	0.00178	CcSEcCtD
Pyrazinamide—Discomfort—Doxorubicin—uterine cancer	0.000271	0.00176	CcSEcCtD
Pyrazinamide—Anorexia—Epirubicin—uterine cancer	0.000271	0.00176	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000259	0.00168	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000258	0.00167	CcSEcCtD
Pyrazinamide—Anorexia—Doxorubicin—uterine cancer	0.000251	0.00162	CcSEcCtD
Pyrazinamide—Dyspepsia—Epirubicin—uterine cancer	0.00025	0.00162	CcSEcCtD
Pyrazinamide—Decreased appetite—Epirubicin—uterine cancer	0.000247	0.0016	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000246	0.00159	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00024	0.00155	CcSEcCtD
Pyrazinamide—Feeling abnormal—Epirubicin—uterine cancer	0.000234	0.00152	CcSEcCtD
Pyrazinamide—Dyspepsia—Doxorubicin—uterine cancer	0.000232	0.0015	CcSEcCtD
Pyrazinamide—Decreased appetite—Doxorubicin—uterine cancer	0.000229	0.00148	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000227	0.00147	CcSEcCtD
Pyrazinamide—Urticaria—Epirubicin—uterine cancer	0.000226	0.00146	CcSEcCtD
Pyrazinamide—Body temperature increased—Epirubicin—uterine cancer	0.000225	0.00146	CcSEcCtD
Pyrazinamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000217	0.0014	CcSEcCtD
Pyrazinamide—Hypersensitivity—Epirubicin—uterine cancer	0.00021	0.00136	CcSEcCtD
Pyrazinamide—Urticaria—Doxorubicin—uterine cancer	0.000209	0.00135	CcSEcCtD
Pyrazinamide—Body temperature increased—Doxorubicin—uterine cancer	0.000208	0.00135	CcSEcCtD
Pyrazinamide—Pruritus—Epirubicin—uterine cancer	0.000201	0.0013	CcSEcCtD
Pyrazinamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000194	0.00126	CcSEcCtD
Pyrazinamide—Pruritus—Doxorubicin—uterine cancer	0.000186	0.00121	CcSEcCtD
Pyrazinamide—Vomiting—Epirubicin—uterine cancer	0.000181	0.00117	CcSEcCtD
Pyrazinamide—Rash—Epirubicin—uterine cancer	0.000179	0.00116	CcSEcCtD
Pyrazinamide—Dermatitis—Epirubicin—uterine cancer	0.000179	0.00116	CcSEcCtD
Pyrazinamide—Nausea—Epirubicin—uterine cancer	0.000169	0.00109	CcSEcCtD
Pyrazinamide—Vomiting—Doxorubicin—uterine cancer	0.000167	0.00108	CcSEcCtD
Pyrazinamide—Rash—Doxorubicin—uterine cancer	0.000166	0.00107	CcSEcCtD
Pyrazinamide—Dermatitis—Doxorubicin—uterine cancer	0.000166	0.00107	CcSEcCtD
Pyrazinamide—Nausea—Doxorubicin—uterine cancer	0.000156	0.00101	CcSEcCtD
